Current Opinion in Lipidology was launched in 1990. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of lipidology is divided into six sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editor for this issue.
SECTION EDITOR
Robert Hegele
;)
Robert Hegele
Dr Rob Hegele is a distinguished University Professor of Medicine and Biochemistry, University of Western Ontario, Canada, and Director of the Lipid Genetics Clinic and the London Regional Genomics Centre in London, Ontario, Canada.
He received his MD degree from the University of Toronto in 1981. His specialty training in internal medicine and in endocrinology & metabolism was also in Toronto. His post-doctoral research fellowships were at Rockefeller University, USA, and Howard Hughes Medical Institute, University of Utah, USA. From 1989 to 1997 he was in the Faculty of Medicine at the University of Toronto. In 1997 Dr Hegele joined the Schulich School of Medicine and Dentistry and the Robarts Research Institute at Western University, in London, Ontario, Canada, where he holds the Jacob J. Wolfe Distinguished Medical Research Chair and the Martha Blackburn Chair in Cardiovascular Research.
His lab studies the genetics of lipoprotein metabolism, cardiovascular disease and diabetes mellitus. Solely or through collaborations, his lab was first to describe the molecular genetic basis of more than 25 human diseases. His lab has also defined much of the genetic basis of complex disorders, including hypertriglyceridemia. He has co-authored over 780 peer-reviewed publications and has contributed to national treatment guidelines for dyslipidemia, hypertension and diabetes. He is a practicing endocrinologist and has participated in many clinical trials of new lipid drugs. He has trained numerous physicians and graduate students.
He received the 2019 American Heart Association Lyman Duff Award and the 2020 Familial Hypercholesterolemia Foundation Pioneer Award.
